Europe’s winter energy crunch may already be underway. Two U.S. stocks that may benefitOctober 2, 2026
AgomAb Therapeutics NV (AGMB) Discusses Open-Label Extension Results of Phase IIa STENOVA Study in Fibrosing Crohn’s Disease TranscriptOctober 2, 2026
Fed’s Kashkari says inflation is ‘still too high’ even after softer-than-expected PCE dataOctober 2, 2026
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in FIGS, Inc. with Losses of $100,000 to Contact the Firm Markets October 21, 2022 LOS ANGELES, CA / ACCESSWIRE / October 20, 2022 / The Schall Regulation Agency, a nationwide shareholder rights litigation agency,…
